Arshag D Mooradian Selected Research

Arshag D Mooradian Research Topics

Disease

13	Insulin Resistance 01/2022 - 01/2002
10	Diabetes Mellitus 01/2021 - 01/2002
10	Cardiovascular Diseases (Cardiovascular Disease) 10/2016 - 04/2004
9	Obesity 10/2019 - 01/2003
8	Type 2 Diabetes Mellitus (MODY) 09/2019 - 01/2002
8	Hepatocellular Carcinoma (Hepatoma) 12/2017 - 03/2002
8	Dyslipidemias (Dyslipidemia) 01/2015 - 01/2003
7	Hyperglycemia 01/2022 - 03/2004
6	Atherosclerosis 01/2022 - 03/2002
6	Coronary Artery Disease (Coronary Atherosclerosis) 10/2019 - 01/2009
5	Coronary Disease (Coronary Heart Disease) 03/2020 - 01/2003
5	Body Weight (Weight, Body) 04/2017 - 07/2004
4	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 01/2004
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 12/2004
3	Hyperthyroidism 11/2019 - 07/2004
3	Hypoalphalipoproteinemias (Hypoalphalipoproteinemia) 08/2014 - 07/2012
2	Hypothyroidism 11/2019 - 11/2011
2	Glucose Intolerance 04/2017 - 06/2008
2	Weight Loss (Weight Reduction) 04/2017 - 07/2015
2	Vascular Diseases (Vascular Disease) 10/2016 - 01/2016
2	Diabetes Complications 01/2016 - 05/2011
2	Renal Insufficiency (Renal Failure) 01/2009 - 01/2002
2	Hypertension (High Blood Pressure) 01/2009 - 01/2003
1	Urinary Incontinence 01/2022
1	Pain (Aches) 01/2022
1	Chronic Pain 01/2022
1	Cognitive Dysfunction 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2021
1	Neoplasms (Cancer) 08/2017
1	Breast Neoplasms (Breast Cancer) 08/2017
1	Myocardial Infarction 07/2016
1	Stroke (Strokes) 07/2016
1	Osteoporosis 01/2016
1	Metabolic Diseases (Metabolic Disease) 08/2014
1	Inflammation (Inflammations) 06/2011
1	Chronic Disease (Chronic Diseases) 06/2011

Drug/Important Bio-Agent (IBA)

13	Apolipoprotein A-I (Apolipoprotein A1)IBA 12/2017 - 03/2002
10	Insulin (Novolin)FDA Link 01/2022 - 01/2004
10	HDL LipoproteinsIBA 09/2014 - 04/2003
9	HDL CholesterolIBA 03/2020 - 04/2003
9	LipidsIBA 06/2014 - 04/2003
7	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2004
7	AntioxidantsIBA 01/2016 - 10/2002
5	Proteins (Proteins, Gene)FDA Link 08/2017 - 01/2003
5	CytokinesIBA 01/2016 - 10/2003
4	Thyroid HormonesIBA 11/2019 - 07/2004
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2019 - 01/2007
4	CholesterolIBA 01/2016 - 03/2009
4	Triglycerides (Triacylglycerol)IBA 03/2013 - 06/2008
4	LDL CholesterolIBA 03/2013 - 06/2008
3	Sweetening Agents (Sweeteners)IBA 01/2022 - 04/2017
3	SugarsIBA 01/2021 - 04/2017
3	EnzymesIBA 12/2017 - 10/2004
3	Vitamin D FDA LinkGeneric 10/2016 - 10/2005
3	AdipokinesIBA 07/2016 - 03/2013
3	VitaminsIBA 08/2014 - 10/2002
3	Insulin-Like Growth Factor I (IGF-1)IBA 05/2007 - 02/2004
2	oxidized low density lipoproteinIBA 03/2013 - 06/2008
2	Nonesterified Fatty Acids (NEFA)IBA 03/2013 - 03/2009
2	AlbuminsIBA 01/2013 - 01/2007
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2010 - 12/2004
2	Biomarkers (Surrogate Marker)IBA 02/2007 - 10/2004
2	LeptinIBA 02/2007 - 12/2004
2	Fatty Acids (Saturated Fatty Acids)IBA 02/2006 - 03/2004
2	Superoxides (Superoxide)IBA 01/2006 - 10/2004
2	ProstaglandinsIBA 03/2004 - 02/2004
2	TransferasesIBA 02/2004 - 04/2003
2	Chloramphenicol (Chloromycetin)FDA Link 02/2004 - 04/2003
1	tagatose (D-tagatose)IBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	psicose (D-psicose)IBA 01/2022
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2022
1	Caspase 3 (Caspase-3)IBA 03/2021
1	InsulinsIBA 12/2018
1	ProteomeIBA 08/2017
1	MonosaccharidesIBA 04/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 11/2016
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2015
1	ebselenIBA 08/2015
1	Glutathione Peroxidase GPX1IBA 08/2015
1	CarbohydratesIBA 07/2015
1	FlavonoidsIBA 08/2014
1	PhytochemicalsIBA 08/2014
1	QuercetinIBA 08/2014
1	PolyphenolsIBA 08/2014
1	Protein Kinases (Protein Kinase)IBA 06/2014
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 06/2014
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 07/2012
1	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 04/2012
1	EndocannabinoidsIBA 04/2012
1	anandamide (arachidonylethanolamide)IBA 04/2012
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 11/2011

Therapy/Procedure

11	Therapeutics 01/2022 - 01/2002
3	Drug Therapy (Chemotherapy) 01/2015 - 01/2004
1	Polypharmacy 01/2022
1	Injections 01/2022
1	Bariatric Surgery 10/2019
1	Fat-Restricted Diet (Diet, Fat Restricted) 07/2015
1	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 07/2015